Ribonucleic Acid News and Research

RSS
New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

7 Nov 2021
Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

7 Nov 2021
Pfizer COVID-19 vaccine elicits durable specific memory T-cell response

Pfizer COVID-19 vaccine elicits durable specific memory T-cell response

4 Nov 2021
“Catching SARS-CoV-2 in the act” – viral infection of nasal mucosa spares nerve cells

“Catching SARS-CoV-2 in the act” – viral infection of nasal mucosa spares nerve cells

4 Nov 2021
Clear communication needed with college students regarding COVID-19 vaccine procedures and cost

Clear communication needed with college students regarding COVID-19 vaccine procedures and cost

4 Nov 2021
Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

3 Nov 2021
Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

3 Nov 2021
Pre-clinical follow-up study boosting with original formulation and next generation INO-4802 SARS-CoV-2 vaccine candidate

Pre-clinical follow-up study boosting with original formulation and next generation INO-4802 SARS-CoV-2 vaccine candidate

3 Nov 2021
Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

2 Nov 2021
The pros and cons of a COVID-19 vaccine booster

The pros and cons of a COVID-19 vaccine booster

2 Nov 2021
End-stage renal disease negatively impacts COVID-19 vaccine response

End-stage renal disease negatively impacts COVID-19 vaccine response

2 Nov 2021
Placental cell-type productively infected with SARS-CoV-2

Placental cell-type productively infected with SARS-CoV-2

2 Nov 2021
Curious case of SARS-CoV-2 Delta variant in a dog

Curious case of SARS-CoV-2 Delta variant in a dog

1 Nov 2021
Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

1 Nov 2021
Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

1 Nov 2021
The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

31 Oct 2021
Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

31 Oct 2021
The ability of natural flavonoids to inhibit SARS-CoV-2

The ability of natural flavonoids to inhibit SARS-CoV-2

31 Oct 2021
Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

28 Oct 2021
How long does natural or vaccine-induced immunity to COVID last?

How long does natural or vaccine-induced immunity to COVID last?

28 Oct 2021

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback